Public Relations

Fastrack eyes Rs 360 crore turnover in FY 2009-10

Fastrack, a branded chain of retail stores from Titan Industries Ltd (TIL), has set the target of Rs. 360 crore sales turn over for the current FY 2009-10. - ICRA upgrades ratings for Titan Inds - Titan raises capex by 43% in FY10 - Titan Industries Q1 net up 41% at Rs 46 cr - Ethical indices outdo benchmarks - Titan to tap rural, semi-urban markets with Sonata watches - Titan sets $1 bn revenue target for current fiscal The company, which just opened first new store in Nashik, is planning to open 38 new stores major cities across the country by March 2010. Moreover, the company is also planning to add few more branded accessories, including helmet, footwear, jewellery and cellphones. With the opening of its new store in Nashik, Fastrack now has 12 stores across the country, including Pune, Thane, Chennai, Bangalore, New Delhi, Hyderabad, Vizag and Bhubaneshwar. Presently, Fastrack stores house the new range of bags, belts, wallets, wristbands, watches and sunglasses. “As part of our expansion plans, we are opening 38 new stores in major cities across the country by the end of the current FY 2009-10. These stores would be a mix of company-owned and franchisee model. An average investment in each store would be around Rs. 30-40 lakh,” Ronnie Talati, Vice-president and Business Head, Fastrack,” told Business Standard. Fastrack registered a sales turn over of Rs. 300 crore in FY 2008-09 and is expecting 20 per cent year on year growth for the next five years, Talati said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Fall in exports has slowed, says Sharma
The government today said though the exports affected by the global slowdown are hovering in the negative zone, the slide has slowed.
Popular Articles

Canon India aims Rs 1,100 cr turnover in 2010
Digital imaging company Canon India is targetting a turnover of Rs 1,100 crore during 2010, a growth of 25 per cent compared to last year, a top official today said.

Sun Pharma : The skies aren't clear yet
The management at Sun Pharma has indicated that sales in the current year could grow by about 13-15 per cent. That’s better than what was expected earlier and is probably because of benefits that it will get from selling a couple of products—Protonix and Ethyol---exclusively in the overseas markets. But it’s good news because the Rs 4,272 crore drug firm has been going through a bit of a rough patch in the US.